Avanir Pharmaceuticals (AVNR)
News
| May 18 | AVANIR PHARMACEUTICALS, INC. Financials |
| May 17 | Avanir Pharmaceuticals CEO Presents at Bank of America Merrill Lynch Health Care Conf... |
| May 16 | Reflections on Arena's AdComm: What's Ahead for Arena, Vivus, Avanir Fool |
| May 10 | $AVNR forms bullish "Continuation Wedge" chart pattern. http://stks.co/3mTw by RecogniaEvents |
| May 10 | $AVNR is 10.1% up since open and 10.5% up since close. by TradeBot |
| May 10 | 6 Cash Heavy Small-Cap Healthcare Stocks Rated As Buys |
| May 10 | $AVNR 200 Day SMA Cross - Price crossed above 200 day SMA (2.8357). Confirmed by volume. by TradeIdeasQuant |
| May 09 | Avanir Pharmaceuticals' Presents at Deutsche Bank Securities Annual Health Care Confe... |
| May 09 | $AVNR filed latest Quarterly Report http://stks.co/3knP by MarketBrief |
| May 09 | AVANIR PHARMACEUTICALS, INC. Files SEC form 8-K, Entry into a Material Definitive Agr... |
| May 08 | $AVNR 200 Day SMA Cross - Price crossed above 200 day SMA (2.8471). Confirmed by volume. by TradeIdeasQuant |
Profile
Exchange: NASDAQGM Sector: Healthcare Industry: Drugs - Generic
1 Year Total Return Performance
This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Avanir Pharmaceuticals is down 39.19% over the last year vs S&P 500 Total Return up 1.62%, Akorn up 106.6%, and LIGAND PHARMACEUTICALS up 21.30%.
- AVNR Total Returns
- ^SPXTR Total Returns
- AKRX Total Returns
- LGND Total Returns
Fundamentals
Fundamental analysis of a business involves analyzing its financial statements and health, its management and competitive advantages. The key financial statements of a company are the income statement, balance sheet and cash flow statement.
Cash Flow Statement View Statement
You may also be interested in these AVNR related companies
Pro Strategies Featuring AVNR
Did Avanir Pharmaceuticals make it into our Pro Portfolio Strategies?
AVNR Charts
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
Other AVNR Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership MSN Money
- SEC Filings SEC
- Technical Charts Chart.ly
- Trading Ideas Benzinga
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| AVNR | 2.84 | +0.02 | +0.71% | 376.87M |
| AVL | 1.45 | -0.01 | -0.68% | |
| AVK | 15.28 | +0.01 | +0.07% | |
| AVII | 0.7185 | -0.01 | -1.58% | 97.53M |
| AVID | 6.68 | -0.11 | -1.62% | 258.45M |
| AVGO | 33.15 | +0.64 | +1.97% | 8.085B |
| AVEO | 12.60 | +0.41 | +3.36% | 544.95M |
| AVD | 25.75 | -0.01 | -0.04% | 710.96M |
| AVCA | 6.199 | +0.26 | +4.36% | 36.08M |
| AVB | 139.84 | -1.30 | -0.92% | 13.31B |
